Ser protease

セリンプロテアーゼ

関

serine protease、serine proteinase

WordNet

1. any enzyme that catalyzes the splitting of proteins into smaller peptide fractions and amino acids by a process known as proteolysis (同)peptidase, proteinase, proteolytic_enzyme
2. the 19th letter of the Roman alphabet (同)s
3. any tropical African shrub of the genus Protea having alternate rigid leaves and dense colorful flower heads resembling cones

PrepTutorEJDIC

1. sulfurの化学記号 / {略}South[ern]
2. seleniumの化学記号

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2017/06/03 06:01:33」(JST)

wiki en

[Wiki en表示]

Serine endopeptidases
Crystal structure of bovine chymotrypsin. The catalytic residues are shown as yellow sticks. Rendered from PDB 1CBW.
Identifiers
EC number	3.4.21.-
Databases
IntEnz	IntEnz view
BRENDA	BRENDA entry
ExPASy	NiceZyme view
KEGG	KEGG entry
MetaCyc	metabolic pathway
PRIAM	profile
PDB structures	RCSB PDB PDBe PDBsum
Search PMC articles PubMed articles NCBI proteins

Crystal structure of Trypsin, a typical serine protease.

Serine proteases (or serine endopeptidases) are enzymes that cleave peptide bonds in proteins, in which serine serves as the nucleophilic amino acid at the (enzyme's) active site. They are found ubiquitously in both eukaryotes and prokaryotes. Serine proteases fall into two broad categories based on their structure: chymotrypsin-like (trypsin-like) or subtilisin-like. In humans, they are responsible for coordinating various physiological functions, including digestion, immune response, blood coagulation and reproduction.

Classification

The MEROPS protease classification system counts 16 superfamilies (as of 2013) each containing many families. Each superfamily uses the catalytic triad or dyad in a different protein fold and so represent convergent evolution of the catalytic mechanism. The majority belong to the S1 family of the PA clan (superfamily) of proteases.

For superfamilies, P = superfamily containing a mixture of nucleophile class families, S = purely serine proteases. superfamily. Within each superfamily, families are designated by their catalytic nucleophile (S = serine proteases).

Families of Serine proteases

Superfamily	Families	Examples
SB	S8, S53	Subtilisin (Bacillus licheniformis)
SC	S9, S10, S15, S28, S33, S37	Prolyl oligopeptidase (Sus scrofa)
SE	S11, S12, S13	D-Ala-D-Ala peptidase C (Escherichia coli)
SF	S24, S26	Signal peptidase I (Escherichia coli)
SH	S21, S73, S77, S78, S80	Cytomegalovirus assemblin (human herpesvirus 5)
SJ	S16, S50, S69	Lon-A peptidase (Escherichia coli)
SK	S14, S41, S49	Clp protease (Escherichia coli)
SO	S74	Phage K1F endosialidase CIMCD self-cleaving protein (Enterobacteria phage K1F)
SP	S59	Nucleoporin 145 (Homo sapiens)
SR	S60	Lactoferrin (Homo sapiens)
SS	S66	Murein tetrapeptidase LD-carboxypeptidase (Pseudomonas aeruginosa)
ST	S54	Rhomboid-1 (Drosophila melanogaster)
PA	S1, S3, S6, S7, S29, S30, S31, S32, S39, S46, S55, S64, S65, S75	Chymotrypsin A (Bos taurus)
PB	S45, S63	Penicillin G acylase precursor (Escherichia coli)
PC	S51	Dipeptidase E (Escherichia coli)
PE	P1	DmpA aminopeptidase (Ochrobactrum anthropi)
unassigned	S48, S62, S68, S71, S72, S79, S81

Substrate specificity

Serine proteases are characterised by a distinctive structure, consisting of two beta-barrel domains that converge at the catalytic active site. These enzymes can be further categorised based on their substrate specificity as either trypsin-like, chymotrypsin-like or elastase-like.

Trypsin-like

Trypsin-like proteases cleave peptide bonds following a positively charged amino acid (lysine or arginine). This specificity is driven by the residue which lies at the base of the enzyme's S1 pocket (generally a negatively charged aspartic acid or glutamic acid).

Chymotrypsin-like

The S1 pocket of chymotrypsin-like enzymes is more hydrophobic than in trypsin-like proteases. This results in a specificity for medium to large sized hydrophobic residues, such as tyrosine, phenylalanine and tryptophan.

Thrombin-like

These include thrombin, tissue activating plasminogen and plasmin. They have been found to have roles in coagulation and digestion as well as in the pathophysiology of neurodegenerative disorders such as Alzheimer's and Parkinson's induced dementia.

Elastase-like

Elastase-like proteases have a much smaller S1 cleft than either trypsin- or chymotrypsin-like proteases. Consequently, residues such as alanine, glycine and valine tend to be preferred.

Subtilisin-like

Subtilisin is a serine protease in prokaryotes. Subtilisin is evolutionarily unrelated to the chymotrypsin-clan, but shares the same catalytic mechanism utilising a catalytic triad, to create a nucleophilic serine. This is the classic example used to illustrate convergent evolution, since the same mechanism evolved twice independently during evolution.

Catalytic mechanism

See also: catalytic triad

The main player in the catalytic mechanism in the serine proteases is the catalytic triad. The triad is located in the active site of the enzyme, where catalysis occurs, and is preserved in all superfamilies of serine protease enzymes. The triad is a coordinated structure consisting of three amino acids: His 57, Ser 195 (hence the name "serine protease") and Asp 102. These three key amino acids each play an essential role in the cleaving ability of the proteases. While the amino acid members of the triad are located far from one another on the sequence of the protein, due to folding, they will be very close to one another in the heart of the enzyme. The particular geometry of the triad members are highly characteristic to their specific function: it was shown that the position of just four points of the triad characterize the function of the containing enzyme.

In the event of catalysis, an ordered mechanism occurs in which several intermediates are generated. The catalysis of the peptide cleavage can be seen as a ping-pong catalysis, in which a substrate binds (in this case, the polypeptide being cleaved), a product is released (the N-terminus "half" of the peptide), another substrate binds (in this case, water), and another product is released (the C-terminus "half" of the peptide).

Each amino acid in the triad performs a specific task in this process:

• The serine has an -OH group that is able to act as a nucleophile, attacking the carbonyl carbon of the scissile peptide bond of the substrate.
• A pair of electrons on the histidine nitrogen has the ability to accept the hydrogen from the serine -OH group, thus coordinating the attack of the peptide bond.
• The carboxyl group on the aspartic acid in turn hydrogen bonds with the histidine, making the nitrogen atom mentioned above much more electronegative.

The whole reaction can be summarized as follows:

• The polypeptide substrate binds to the surface of the serine protease enzyme such that the scissile bond is inserted into the active site of the enzyme, with the carbonyl carbon of this bond positioned near the nucleophilic serine.
• The serine -OH attacks the carbonyl carbon, and the nitrogen of the histidine accepts the hydrogen from the -OH of the [serine] and a pair of electrons from the double bond of the carbonyl oxygen moves to the oxygen. As a result, a tetrahedral intermediate is generated.
• The bond joining the nitrogen and the carbon in the peptide bond is now broken. The covalent electrons creating this bond move to attack the hydrogen of the histidine, breaking the connection. The electrons that previously moved from the carbonyl oxygen double bond move back from the negative oxygen to recreate the bond, generating an acyl-enzyme intermediate.
• Now, water comes into the reaction. Water replaces the N-terminus of the cleaved peptide, and attacks the carbonyl carbon. Once again, the electrons from the double bond move to the oxygen making it negative, as the bond between the oxygen of the water and the carbon is formed. This is coordinated by the nitrogen of the histidine, which accepts a proton from the water. Overall, this generates another tetrahedral intermediate.
• In a final reaction, the bond formed in the first step between the serine and the carbonyl carbon moves to attack the hydrogen that the histidine just acquired. The now electron-deficient carbonyl carbon re-forms the double bond with the oxygen. As a result, the C-terminus of the peptide is now ejected.

Additional stabilizing effects

It was discovered that additional amino acids of the protease, Gly 193 and Ser 195, are involved in creating what is called an oxyanion hole. Both Gly 193 and Ser 195 can donate backbone hydrogens for hydrogen bonding. When the tetrahedral intermediate of step 1 and step 3 are generated, the negative oxygen ion, having accepted the electrons from the carbonyl double bond fits perfectly into the oxyanion hole. In effect, serine proteases preferentially bind the transition state and the overall structure is favored, lowering the activation energy of the reaction. This "preferential binding" is responsible for much of the catalytic efficiency of the enzyme.

Regulation of Serine Protease activity

Host organisms must ensure that the activity of serine proteases is adequately regulated. This is achieved by a requirement for initial protease activation, and the secretion of inhibitors.

Zymogen activation

Zymogens are the usually inactive precursors of an enzyme. If the digestive enzymes were active when synthesized, they would immediately start chewing up the synthesizing organs and tissues. Acute pancreatitis is such a condition, in which there is premature activation of the digestive enzymes in the pancreas, resulting in self-digestion (autolysis). It also complicates postmortem investigations, as the pancreas often digests itself before it can be assessed visually.

Zymogens are large, inactive structures, which have the ability to break apart or change into the smaller activated enzymes. The difference between zymogens and the activated enzymes lies in the fact that the active site for catalysis of the zymogens is distorted. As a result, the substrate polypeptide cannot bind effectively, and proteolysis does not occur. Only after activation, during which the conformation and structure of the zymogen change and the active site is opened, can proteolysis occur.

Zymogen	Enzyme	Notes
Trypsinogen	trypsin	When trypsinogen enters the small intestine from the pancreas, enteropeptidase secretions from the duodenal mucosa cleave the lysine 15 - isoleucine 16 peptide bond of the zymogen. As a result, the zymogen trypsinogen breaks down into trypsin. Recall that trypsin is also responsible for cleaving lysine peptide bonds, and thus, once a small amount of trypsin is generated, it participates in cleavage of its own zymogen, generating even more trypsin. The process of trypsin activation can thus be called autocatalytic.
Chymotrypsinogen	chymotrypsin	After the Arg 15 - Ile 16 bond in the chymotrypsinogen zymogen is cleaved by trypsin, the newly generated structure called a pi-chymotrypsin undergoes autolysis (self digestion), yielding active chymotrypsin.
Proelastase	elastase	It is activated by cleavage through trypsin.

As can be seen, trypsinogen activation to trypsin is essential, because it activates its own reaction, as well as the reaction of both chymotrypsin and elastase. Therefore, it is essential that this activation does not occur prematurely. There are several protective measures taken by the organism to prevent self-digestion:

• The activation of trypsinogen by trypsin is relatively slow
• The zymogens are stored in zymogen granules, capsules that have walls that are thought to be resistant to proteolysis.

Inhibition

There are certain inhibitors that resemble the tetrahedral intermediate, and thus fill up the active site, preventing the enzyme from working properly. Trypsin, a powerful digestive enzyme, is generated in the pancreas. Inhibitors prevent self-digestion of the pancreas itself.

Serine proteases are paired with serine protease inhibitors, which turn off their activity when they are no longer needed.

Serine proteases are inhibited by a diverse group of inhibitors, including synthetic chemical inhibitors for research or therapeutic purposes, and also natural proteinaceous inhibitors. One family of natural inhibitors called "serpins" (abbreviated from serine protease inhibitors) can form a covalent bond with the serine protease, inhibiting its function. The best-studied serpins are antithrombin and alpha 1-antitrypsin, studied for their role in coagulation/thrombosis and emphysema/A1AT, respectively. Artificial irreversible small molecule inhibitors include AEBSF and PMSF.

A family of arthropod serine peptidase inhibitors, called pacifastin, has been identified in locusts and crayfish, and may function in the arthropod immune system.

Role in disease

Mutations may lead to decreased or increased activity of enzymes. This may have different consequences, depending on the normal function of the serine protease. For example, mutations in protein C can lead to protein C deficiency and predisposing to thrombosis.

Diagnostic use

Determination of serine protease levels may be useful in the context of particular diseases.

• Coagulation factor levels may be required in the diagnosis of hemorrhagic or thrombotic conditions.
• Fecal elastase is employed to determine the exocrine activity of the pancreas, e.g., in cystic fibrosis or chronic pancreatitis.
• Serum prostate-specific antigen is used in prostate cancer screening, risk stratification, and post-treatment monitoring.
• Serine protease, as released by mast cells, is an important diagnostic marker for type 1 hypersensitivity reactions (e.g. anaphylaxis). More useful than e.g. histamine due to the longer half-life, meaning it remains in the system for a clinically useful length of time.

See also

• Serine hydrolase
• Protease
  • cysteine-
  • threonine-
  • aspartic-
  • metallo-
• PA clan
• Convergent evolution
• Proteolysis
• Catalytic triad
• The Proteolysis Map
• Proteases in angiogenesis
• Intramembrane proteases
• Protease inhibitor (pharmacology)
• Protease inhibitor (biology)
• TopFIND - database of protease specificity, substrates, products and inhibitors
• MEROPS - Database of protease evolutionary groups

References

External links

• The MEROPS online database for peptidases and their inhibitors: Serine Peptidase
• Serine Proteases site at Saint Louis University (SLU)
• Serine proteases at the US National Library of Medicine Medical Subject Headings (MeSH)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. C型肝炎ウイルス感染に対する試験的治療 investigational therapies for hepatitis c virus infection
• 2. 妊娠時の抗レトロウイルス剤：プロテアーゼ阻害剤 antiretroviral medications in pregnancy protease inhibitors
• 3. 遺伝子1型慢性C型肝炎の治療レジメン treatment regimens for chronic hepatitis c virus genotype 1
• 4. HIV抗レトロウイルス療法に関する臨床試験：ブーストしたプロテアーゼ阻害剤の単剤療法試験 clinical trials of hiv antiretroviral therapy boosted protease inhibitor monotherapy studies
• 5. HIVプロテアーゼ阻害剤 hiv protease inhibitors

English Journal

• Recognition of corn defense chitinases by fungal polyglycine hydrolases.

• Naumann TA1, Bakota EL2, Price NPJ3.
• Protein science : a publication of the Protein Society.Protein Sci.2017 Jun;26(6):1214-1223. doi: 10.1002/pro.3175. Epub 2017 Apr 16.
• PMID 28383143

• High-resolution mass spectrometry confirms the presence of a hydroxyproline (Hyp) post-translational modification in the GGGGP linker of an Fc-fusion protein.

• Spahr C1, Gunasekaran K2, Walker KW2, Shi SD1.
• mAbs.MAbs.2017 May 16:0. doi: 10.1080/19420862.2017.1325556. [Epub ahead of print]
• PMID 28506197

• Conformational and functional transitions and in silico analysis of a serine protease from Conidiobolus brefeldianus (MTCC 5185).

• Shukla E1, Agrawal SB1, Gaikwad SM2.
• International journal of biological macromolecules.Int J Biol Macromol.2017 May;98:387-397. doi: 10.1016/j.ijbiomac.2017.01.124. Epub 2017 Jan 30.
• PMID 28153464

Japanese Journal

• 血栓症を発症した複合ヘテロ接合体性プロテインC欠乏症患者で認められた2種の遺伝子変異とそれぞれのプロテインC産生に及ぼす影響

• 油井 知雄,越智 守生,高橋 伸彦,家子 正裕,林 辰弥,鈴木 宏治
• 日本血栓止血学会誌 22(3), 87-99, 2011
• … uence法によりPC遺伝子上の変異部位を同定するとともに，PCR-Restriction fragment length polymorphism（RFLP）法により，その家系の遺伝子型の精査を行った．PCR-Direct sequenceにより，発端者PC遺伝子の第9エクソン上にGly282→Ser変異（変異I）およびMet364→Ile（変異II）を認め，PCR-RFLP法による発端者家族の遺伝子型の解析により，2種の変異は異なるアレルに存在することが明らかになった．さらに，Site-directed mutagenesis法を用いて，変異 …
• NAID 130000823243

• Macelignan Inhibits Melanosome Transfer Mediated by Protease-Activated Receptor-2 in Keratinocytes

• Choi Eun-Jung,Kang Young-Gyu,Kim Jaekyung,Hwang Jae-Kwan
• Biological & Pharmaceutical Bulletin 34(5), 748-754, 2011
• … Protease-activated receptor-2 (PAR-2) is a key mediator of melanosome transfer, which occurs as the melanocyte extends its dendrite toward surrounding keratinocytes that take up melanosomes by phagocytosis. … HaCaT cells stimulated by the PAR-2-activating peptide Ser-Leu-Ile-Gly-Arg-Leu-NH2 (SLIGRL) were treated with macelignan; …
• NAID 130000657790

Related Links

• Products | Ser/Thr Protease

Product Name Catalog No. Brief Description Nafamostat HY-B0190 Nafamostat is a broad spectrum serine protease inhibitor, kallikrein inhibitor, and inhibits blood coagulation; is also a possible complement inhibitor. Nafamostat ...

• ser protease sequence - Bing Dictionary

必应词典为您提供ser protease sequence的释义，网络释义： 比较； ... Enzyme slide list 5-8 ... Metal,Ser,Cys,Asp 四大类 Ser protease sequence 比较 Molecular evolution 分子演化 ...

Related Pictures

---

★リンクテーブル★

リンク元	「serine proteinase」「serine protease」
関連記事	「SER」「Ser」「S」「Se」

「serine proteinase」

　　[★]

セリンプロテイナーゼ、セリンプロテアーゼ

関

Ser protease、serine endopeptidase、serine protease

「serine protease」

　　[★]

セリンプロテアーゼ

関

Ser protease、serine endopeptidase、serine proteinase

「SER」

　　[★]

• セリン serine
• 滑面小胞体 smooth endoplasmic reticulum
• セルトラリン sertraline

「Ser」

　　[★]

セリン

関

S、serine

同

セリン

「S」

　　[★]

• セリン serine
• 胸骨上縁

　 　

「Se」

　　[★] セレン selenium